Legacy Clinics Primary Care is categorized under Commercial Research Laboratory in Lake Oswego, OR and active since 2009.
Legacy Clinics Primary Care was established in 2009, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Commercial Research Laboratory business, which does work in the B2B market, and is classified as a Commercial Research Laboratory, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Karl Kaluza at the company’s single location by writing to 412 A Avenue, Lake Oswego, Oregon OR 97034 or by phoning (503) 635-2496. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Legacy Clinics Primary Care |
| Contact Person: | Karl Kaluza |
| Address: | 412 A Avenue, Lake Oswego, Oregon 97034 |
| Phone Number: | (503) 635-2496 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Research Laboratory |
| SIC Code: | 8731 |
| NAICS Code: | 6214930 |
| Share This Business: |
Legacy Clinics Primary Care was started in 2009 to provide professional Commercial Research Laboratory under the SIC code 8731 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Karl Kaluza for inquiries that concern Legacy Clinics Primary Care by calling the company number (503) 635-2496, as your correspondence is most welcome. Additionally, the physical location of the single location of Legacy Clinics Primary Care can be found at the coordinates 45.41971,-122.66822 as well as the street address 412 A Avenue in Lake Oswego, Oregon 97034.
For its online presence, you may visit Legacy Clinics Primary Care’s website at and engage with its social media outlets through on Twitter and on Facebook.